Differences in colon and rectal cancer chemosensitivity

• Siegel R , NaishadhamD, JemalA. Cancer statistics, 2013. CA Cancer J. Clin.63, 11–30 (2013).
   PubMed Web of Science ®Google Scholar
• Martling AL , HolmT, RutqvistLE, MoranBJ, HealdRJ, CedemarkB. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet356, 93–96 (2000).
   PubMed Web of Science ®Google Scholar
• Bosch SL , NagtegaalID. The importance of the pathologist‘s role in assessment of the quality of the mesorectum. Curr. Colorectal Cancer Rep.8, 90–98 (2012).
   PubMedGoogle Scholar
• Kapiteijn E , MarijnenCA, NagtegaalIDet al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345, 638–646 (2001).
   PubMed Web of Science ®Google Scholar
• Sauer R , LierschT, MerkelSet al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized Phase III trial after a median follow-up of 11 years. J. Clin. Oncol. 30, 1926–1933 (2012).
   PubMed Web of Science ®Google Scholar
• Grundmann RT . Current state of surgical treatment of liver metastases from colorectal cancer. World J. Gastrointest. Surg.3, 183–196 (2011).
   PubMedGoogle Scholar
• Kemeny NE . Changing paradigms for liver resection of colorectal metastases. Ann. Surg. Oncol.19, 2773–2775 (2012).
   PubMed Web of Science ®Google Scholar
• Gallagher DJ , KemenyN. Metastatic colorectal cancer: from improved survival to potential cure. Oncology78, 237–248 (2010).
   PubMed Web of Science ®Google Scholar
• Chu E . An update on the current and emerging targeted agents in metastatic colorectal cancer. Clin. Colorectal Cancer11, 1–13 (2012).
   PubMed Web of Science ®Google Scholar
• Moertel CG , FlemingTR, MacdonaldJSet al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322, 352–358 (1990).
   PubMed Web of Science ®Google Scholar
• Graham JS , CassidyJ. Adjuvant therapy in colon cancer. Expert Rev. Anticancer Ther.12, 99–109 (2012).
   PubMed Web of Science ®Google Scholar
• Link KH , KornmannM, StaibLet al. Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha. Ann. Surg. 242, 178–187 (2005).
   PubMed Web of Science ®Google Scholar
• Wolmark N , WieandHS, HyamsDMet al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J. Natl Cancer Inst. 92, 388–396 (2000).
   PubMed Web of Science ®Google Scholar
• Tepper JE , O‘ConnellM, NiedzwieckiDet al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control – final report of intergroup 0114. J. Clin. Oncol. 20, 1744–1750 (2002).
   PubMed Web of Science ®Google Scholar
• Bosset JF , ColletteL, CalaisGet al.; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med.355, 1114–1123 (2006).
   PubMed Web of Science ®Google Scholar
• Peeters KC , MarijnenCA, NagtegaalIDet al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. 246, 693–701 (2007).
   PubMed Web of Science ®Google Scholar
• Kornmann M , StaibL, WiegelTet al. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α. Br. J. Cancer 103, 1163–1172 (2010).
   PubMed Web of Science ®Google Scholar
• Valentini V , van Stiphout RG, Lammering Get al. Normograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J. Clin. Oncol.29, 3163–3172 (2011).
   PubMed Web of Science ®Google Scholar
• Petersen SH , HarlingH, KirkebyLT, Wille-J⊘rgensenP, MocellinS. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst. Rev.3, CD004078(2012).
   PubMed Web of Science ®Google Scholar
• Dahl O , Fluge Ø, Carlsen Eet al. Final results of a randomised phase III study on adjuvant chemotherapy with 5-FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncol.48, 368–376 (2009).
   PubMed Web of Science ®Google Scholar
• Windle R , BellPR, ShawD. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br. J. Surg.74, 569–572 (1987).
   PubMed Web of Science ®Google Scholar
• Buyse M , Zeleniuch-JacquotteA, ChalmersTC. Adjuvant therapy of colorectal cancer. Why we still don‘t know. JAMA259, 3571–3578 (1988).
   PubMed Web of Science ®Google Scholar
• Laurie JA , MoertelCG, FlemingTRet al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J. Clin. Oncol. 7, 1447–1456 (1989).
   PubMed Web of Science ®Google Scholar
• Wolmark N , FisherB, RocketteHet al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J. Natl Cancer Inst. 80, 30–36 (1988).
   PubMed Web of Science ®Google Scholar
• Fisher B , WolmarkN, RocketteHet al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl Cancer Inst. 80, 21–29 (1988).
   PubMed Web of Science ®Google Scholar
• Gastrointestinal T umor Study Group (GITSG). Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med.312, 1465–1472 (1985).
   PubMed Web of Science ®Google Scholar
• Krook JE , MoertelCG, GundersonLLet al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324, 709–715 (1991).
   PubMed Web of Science ®Google Scholar
• O‘Connell MJ , MartensonJA, WieandHSet al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331, 502–507 (1994).
   PubMed Web of Science ®Google Scholar
• Schmoll HJ , Van Cutsem E, Stein Aet al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann. Oncol.23, 2479–2516 (2012).
   PubMed Web of Science ®Google Scholar
• Pox C , AretzS, BischoffSCet al. S3-guideline colorectal cancer version 1.0. Z. Gastroenterol. 51, 753–854 (2013).
   PubMed Web of Science ®Google Scholar
• Gunderson LL , JessupJM, SargentDJ, GreeneFL, StewartAK. Revised TN categorization for colon cancer based on national survival outcomes data. J. Clin. Oncol.28, 264–271 (2010).
   PubMed Web of Science ®Google Scholar
• Martel G , CrawfordA, BarkunJS, BousheyRP, RamsayCR, FergussonDA. Expert opinion on laparoscopic surgery for colorectal cancer parallels evidence from a cumulative meta-analysis of randomized controlled trials. PLoS ONE7, e35292 (2012).
   PubMed Web of Science ®Google Scholar
• Hohenberger W , WeberK, MatzelK, PapadopoulosT, MerkelS. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis.11, 354–364 (2009).
   PubMed Web of Science ®Google Scholar
• West NP , KobayashiH, TakahashiKet al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J. Clin. Oncol. 30, 1763–1769 (2012).
   PubMed Web of Science ®Google Scholar
• Bethune WA . Carcinoma of the rectum: 508 patients with failure analysis and implication for adjuvant therapy. Can. Assoc. Radiol. J.38, 209–214 (1987).
   PubMed Web of Science ®Google Scholar
• Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N. Engl. J. Med.336, 980–987 (1997).
   PubMed Web of Science ®Google Scholar
• Martling A , CedermarkB, JohanssonH, RutqvistLE, HolmT. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br. J. Surg.89, 1008–1013 (2002).
   PubMed Web of Science ®Google Scholar
• Wibe A , M⊘llerB, NorsteinJet al. A national strategic change in treatment policy for rectal cancer – implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis. Colon Rectum 45, 857–866 (2002).
   PubMed Web of Science ®Google Scholar
• Kube R , PtokH, WolffS, LippertH, Gastinger I; Study Group Colon/Rectum Carcinoma (Primary Tumour). Quality of medical care in colorectal cancer in Germany. Onkologie32, 25–29 (2009).
   PubMedGoogle Scholar
• Saltz LB . Adjuvant therapy for colon cancer. Surg. Oncol. Clin. N. Am.19, 819–827 (2010).
   PubMed Web of Science ®Google Scholar
• Kornmann M , StaibL, WiegelTet al. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer. Clin. Colorectal Cancer 12, 54–61 (2013).
   PubMed Web of Science ®Google Scholar
• André T , BoniC, NavarroMet al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J. Clin. Oncol. 27, 3109–3116 (2009).
   PubMed Web of Science ®Google Scholar
• Yothers G , O‘ConnellMJ, AllegraCJet al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J. Clin. Oncol. 29, 3768–3774 (2011).
   PubMed Web of Science ®Google Scholar
• Twelves C , ScheithauerW, McKendrickJet al. Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Ann. Oncol. 23, 1190–1197 (2012).
   PubMed Web of Science ®Google Scholar
• Haller DG , TaberneroJ, MarounJet al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J. Clin. Oncol. 29, 1465–1471 (2011).
   PubMed Web of Science ®Google Scholar
• van Gijn W , MarijnenCA, NagtegaalIDet al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomized controlled TME trial. Lancet Oncol. 12, 575–582 (2011).
   PubMed Web of Science ®Google Scholar
• McCarthy K , PearsonK, FultonR, HewittJ. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst. Rev.12, CD008368 (2012).
   PubMedGoogle Scholar
• Collette L , BossetJF, den Dulk Met al. Patients with curative resection of cT3–4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J. Clin. Oncol.25, 4379–4386 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson VM , BensonAB 3rd. Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy. Curr. Oncol. Rep.15, 152–161 (2013).
   PubMed Web of Science ®Google Scholar
• Khrizman P , NilandJC, ter Veer Aet al. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J. Clin. Oncol.31, 30–38 (2013).
   PubMedGoogle Scholar
• QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet355, 1588–1596 (2000).
   PubMed Web of Science ®Google Scholar
• Rödel C , LierschT, BeckerHet al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised Phase 3 trial. Lancet Oncol. 13, 679–687.
   PubMed Web of Science ®Google Scholar
• Bonnetain F , BossetJF, GerardJPet al. What is the clinical benefit of preoperative chemoradiotherapy with 5-FU/leucovorin for T3–4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur. J. Cancer 48(12), 1781–1790 (2012).
   PubMed Web of Science ®Google Scholar
• Aschele C , CioniniL, LonardiSet al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized Phase III trial. J. Clin. Oncol. 29, 2773–2780 (2011).
   PubMed Web of Science ®Google Scholar
• Hofheinz RD , WenzF, PostSet al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, Phase 3 trial. Lancet Oncol. 13, 579–588 (2012).
   PubMed Web of Science ®Google Scholar
• Gérard JP , AzriaD, Gourgou-BourgadeSet al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J. Clin. Oncol. 30, 4558–4565 (2012).
   PubMed Web of Science ®Google Scholar
• Roh MS , YothersGA, O‘ConnellMJet al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. J. Clin. Oncol. 29(Suppl.), Abstract 3503 (2011).
   Google Scholar
• Barleben A , MillsS. Anorectal anatomy and physiology. Surg. Clin. North Am.90, 1–15 (2010).
   PubMed Web of Science ®Google Scholar
• Dujovny N , QuirosRM, SaclaridesTJ. Anorectal anatomy and embryology. Surg. Oncol. Clin. N. Am.13, 277–293 (2004).
   PubMedGoogle Scholar
• Staib L , LinkKH, BlatzA, BegerHG. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients – monoinstitutional experience. World J. Surg.26, 59–66 (2002).
   PubMed Web of Science ®Google Scholar
• Hemminki K , SantiI, WeiresM, ThomsenH, SundquistJ, BermejoJL. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer10, 688 (2010).
   PubMed Web of Science ®Google Scholar
• Benedix F , KubeR, MeyerF, SchmidtU, GastingerI, Lippert H; Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis. Colon Rectum53, 57–64 (2010).
   PubMed Web of Science ®Google Scholar
• Yamauchi M , MorikawaT, KuchibaAet al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61, 847–854 (2012).
   PubMed Web of Science ®Google Scholar
• Benedix F , SchmidtU, MroczkowskiP, GastingerI, LippertH, Kube R; Study Group ‘Colon/Rectum Carcinoma (Primary Tumor)‘. Colon carcinoma – classification into right and left sided cancer or according to colonic subsite? – analysis of 29,568 patients. Eur. J. Surg. Oncol.37, 134–139 (2011).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144, 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Iwaizumi M , Tseng-RogenskiS, CarethersJM. Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity. Mutat. Res.747, 19–27 (2013).
   PubMed Web of Science ®Google Scholar
• Meyers M , WagnerMW, HwangHS, KinsellaTJ, BoothmanDA. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res.61, 5193–5201 (2001).
   PubMed Web of Science ®Google Scholar
• Rebucci M , MichielsC. Molecular aspects of cancer cell resistance to chemotherapy. Biochem. Pharmacol.85, 1219–1226 (2013).
   PubMed Web of Science ®Google Scholar
• Zahreddine H , BordenKL. Mechanisms and insights into drug resistance in cancer. Front. Pharmacol.4, 28 (2013).
   PubMed Web of Science ®Google Scholar
• Kawahara A , AkagiY, HattoriSet al. Higher expression of deoxyuridine triphosphatase (dUTPase) may predict the metastasis potential of colorectal cancer. J. Clin. Pathol. 62, 364–369 (2009).
   PubMed Web of Science ®Google Scholar
• Akagi Y , KinugasaT, MizobeT, KawaharaA, KageM, ShirouzuK. Expression of dihydropyrimidine dehydrogenase, orotate phosphoribosyl transferase and thymidylate synthase in patients with primary colorectal cancer, and associations with site of first metastasis. Anticancer Res.32, 2277–2282 (2012).
   PubMed Web of Science ®Google Scholar
• Tanaka K , SaigusaS, ToiyamaYet al. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy. J. Surg. Oncol. 105, 529–534 (2012).
   PubMed Web of Science ®Google Scholar
• Popat S , MatakidouA, HoulstonRS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J. Clin. Oncol.22, 529–536 (2004).
   PubMed Web of Science ®Google Scholar
• Kornmann M , HebartH, DanenbergKet al. Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trial. Eur. J. Cancer 48, 1443–1451 (2012).
   PubMed Web of Science ®Google Scholar
• Gorlick R , MetzgerR, DanenbergKDet al. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J. Clin. Oncol. 16, 1465–1469 (1998).
   PubMed Web of Science ®Google Scholar
• Yamada H , IchikawaW, UetakeHet al. Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites. Clin. Colorectal Cancer 1, 169–173 (2001).
   PubMedGoogle Scholar

Website

• Benson AB 3rd, Bekaii-Saab T, Chan E et al. NCCN Rectal Cancer Guidelines. Version 4.2013. www.nccn.org/professionals/physician_gls/recently_updated.asp
   Google Scholar